245 related articles for article (PubMed ID: 9040820)
1. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
Eisenberg MB; Woloschak M; Sen C; Wolfe D
Surg Neurol; 1997 Feb; 47(2):156-60; discussion 160-1. PubMed ID: 9040820
[TBL] [Abstract][Full Text] [Related]
2. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
Pamir MN; Ozduman K
Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
[TBL] [Abstract][Full Text] [Related]
3. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
4. Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.
Vuong HG; Dunn IF
World Neurosurg; 2022 Jun; 162():e635-e639. PubMed ID: 35339711
[TBL] [Abstract][Full Text] [Related]
5. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
[TBL] [Abstract][Full Text] [Related]
7. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Hug EB; Slater JD
Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
[TBL] [Abstract][Full Text] [Related]
8. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of skull base chondrosarcomas.
Kanamori H; Kitamura Y; Kimura T; Yoshida K; Sasaki H
J Neurosurg; 2015 Oct; 123(4):1036-41. PubMed ID: 26162041
[TBL] [Abstract][Full Text] [Related]
10. Kinase Activity in Recurring Primary Skull Base Chordomas and Chondrosarcomas: Identification of Novel Pathways of Oncogenesis and Potential Drug Targets.
Tatman PD; Osbun J; Yakkioui Y; Kaur S; Parada C; Busald T; Born D; Ahmad O; Zhang J; Ferreira M
World Neurosurg; 2017 Nov; 107():75-81. PubMed ID: 28647652
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.
Horbinski C; Oakley GJ; Cieply K; Mantha GS; Nikiforova MN; Dacic S; Seethala RR
Arch Pathol Lab Med; 2010 Aug; 134(8):1170-6. PubMed ID: 20670138
[TBL] [Abstract][Full Text] [Related]
12. Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas.
Mercado CE; Holtzman AL; Rotondo R; Rutenberg MS; Mendenhall WM
Head Neck; 2019 Feb; 41(2):536-541. PubMed ID: 30537295
[TBL] [Abstract][Full Text] [Related]
13. Skull Base Chordomas and Chondrosarcomas.
Kremenevski N; Schlaffer SM; Coras R; Kinfe TM; Graillon T; Buchfelder M
Neuroendocrinology; 2020; 110(9-10):836-847. PubMed ID: 32541136
[TBL] [Abstract][Full Text] [Related]
14. Chordoma of the skull base: predictors of tumor recurrence.
Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
[TBL] [Abstract][Full Text] [Related]
15. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
Santoni R; Liebsch N; Finkelstein DM; Hug E; Hanssens P; Goitein M; Smith AR; O'Farrell D; Efird JT; Fullerton B; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):59-68. PubMed ID: 9588918
[TBL] [Abstract][Full Text] [Related]
16. Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?
Sawyer JR; Husain M; Al-Mefty O
Neurosurg Focus; 2001 Mar; 10(3):E6. PubMed ID: 16734409
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions.
Schulz-Ertner D; Haberer T; Jäkel O; Thilmann C; Krämer M; Enghardt W; Kraft G; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):36-42. PubMed ID: 12007939
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract][Full Text] [Related]
20. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
